320 related articles for article (PubMed ID: 18721496)
1. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
[TBL] [Abstract][Full Text] [Related]
2. [Ovarian function in young women after anticancer treatment in childhood].
Krawczuk-Rybak M; Leszczyńska E; Zelazowska-Rutkowska B; Wysocka J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1028-34. PubMed ID: 19531821
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
van Beek RD; van den Heuvel-Eibrink MM; Laven JS; de Jong FH; Themmen AP; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2007 Oct; 92(10):3869-74. PubMed ID: 17726078
[TBL] [Abstract][Full Text] [Related]
4. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
5. [Gonadal and thyroid function after treatment for Hodgkin's lymphoma in adolescents].
Krawczuk-Rybak M; Płonowski M; Solarz E; Leszczyńska E; Wojtkowska M; Wysocka J; Szreniawska A; Oleński J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1014-20. PubMed ID: 19531819
[TBL] [Abstract][Full Text] [Related]
6. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
7. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
8. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
9. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
10. The progressive reduction in the ovarian reserve in young women after anticancer treatment.
Krawczuk-Rybak M; Leszczynska E; Poznanska M; Zelazowska-Rutkowska B; Wysocka J
Horm Metab Res; 2013 Oct; 45(11):813-9. PubMed ID: 23950034
[TBL] [Abstract][Full Text] [Related]
11. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
[TBL] [Abstract][Full Text] [Related]
12. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
13. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
14. Ovarian function in female survivors of childhood malignancies.
El-Shalakany AH; Ali MS; Abdelmaksoud AA; Abd El-Ghany S; Hasan EA
Pediatr Hematol Oncol; 2013 May; 30(4):328-35. PubMed ID: 23574301
[TBL] [Abstract][Full Text] [Related]
15. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
16. Acute onset of ovarian dysfunction in young females after start of cancer treatment.
Mörse H; Elfving M; Lindgren A; Wölner-Hanssen P; Andersen CY; Øra I
Pediatr Blood Cancer; 2013 Apr; 60(4):676-81. PubMed ID: 23015461
[TBL] [Abstract][Full Text] [Related]
17. [Gonadal function in young men after the treatment for Hodgkin lymphoma].
Krawczuk-Rybak M; Solarz E; Wojtkowska M; Wysocka J; Matysiak M; Gadomski A; Kazanowska B; Sega-Pondel D
Pediatr Endocrinol Diabetes Metab; 2009; 15(2):85-92. PubMed ID: 19772815
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence].
Roshchina NV; Tsyrlina EV; Punanov IuA; Safonova SA; Bershteĭn LM; Kostromina EV; Malinin AP; Morozova EV
Vopr Onkol; 2014; 60(3):360-5. PubMed ID: 25033691
[TBL] [Abstract][Full Text] [Related]
19. [Testicular function in young men treated in prepubertal period for childhood malignancy].
Krawczuk-Rybak M; Solarz E; Wysocka J; Wojtkowska M; Matysiak M; Gadomski A; Kazanowska B; Sega-Pondel D
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):93-8. PubMed ID: 18721495
[TBL] [Abstract][Full Text] [Related]
20. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.
Lie Fong S; Lugtenburg PJ; Schipper I; Themmen AP; de Jong FH; Sonneveld P; Laven JS
Hum Reprod; 2008 Mar; 23(3):674-8. PubMed ID: 18216040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
